Hybrid Conferencee

International Conference on Oncology and Translational Medicine (ICOTM - 26)

24th - 25th October 2026 | Dubai, UAE

10% DISCOUNT

Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.

REVEAL OFFER
EARLY10
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Dubai. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Dubai event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Dubai conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Dubai, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Dubai."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Immunotherapy

This track will explore the latest breakthroughs in immunotherapy for cancer treatment, focusing on novel approaches and combination therapies. Discussions will include the mechanisms of action, clinical outcomes, and future directions in immunotherapeutic strategies.

Track 02

Precision Medicine in Oncology

This session will delve into the role of precision medicine in tailoring cancer treatment based on individual genetic profiles. Participants will examine case studies and emerging technologies that enhance personalized therapeutic approaches.

Track 03

Tumor Microenvironment and Biology

This track will investigate the complex interactions within the tumor microenvironment and their implications for cancer progression and therapy resistance. Emphasis will be placed on cellular and molecular mechanisms that influence tumor biology.

Track 04

Clinical Trials and Innovative Protocols

This session will highlight the design and implementation of innovative clinical trial protocols in oncology. Key topics will include adaptive trial designs, patient recruitment strategies, and the integration of real-world evidence.

Track 05

Cancer Prevention and Early Detection

This track will focus on strategies for cancer prevention and the importance of early detection in improving patient outcomes. Discussions will include screening guidelines, risk assessment, and public health initiatives.

Track 06

Health Policy and Cancer Care

This session will address the impact of health policy on cancer care delivery and access to treatment. Participants will explore policy frameworks, funding mechanisms, and the role of advocacy in shaping oncology practices.

Track 07

Emerging Targets in Cancer Therapy

This track will examine novel therapeutic targets in cancer biology and their potential for drug development. Discussions will focus on the identification of biomarkers and the translation of laboratory findings into clinical applications.

Track 08

Pediatric Oncology: Challenges and Innovations

This session will address the unique challenges faced in pediatric oncology, including treatment-related toxicities and long-term survivorship. Innovative approaches to therapy and supportive care will be highlighted.

Track 09

Integrative Approaches in Cancer Treatment

This track will explore the integration of complementary and alternative medicine in conventional cancer treatment. Emphasis will be placed on evidence-based practices and patient-centered care.

Track 10

Cancer Genomics and Biomarkers

This session will focus on the role of cancer genomics in identifying biomarkers for diagnosis and treatment. Participants will discuss the implications of genomic data for personalized oncology.

Track 11

Global Perspectives on Oncology Research

This track will provide a platform for discussing global trends and challenges in oncology research. Participants will share insights on collaborative efforts, resource allocation, and disparities in cancer care worldwide.